Factors contributing to this result include the use of metformin and GLP-1 in T2DM patients, increased Irisin secretion due to elevated serum FNDC5 levels, elevated serum TGF-β1, and dietary changes in T2DM patients. This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.